What is Bluepoint Laboratories’ imatinib mesylate?
Bluepoint Laboratories is a company associated with branded and/or distributed generic medicines. “Imatinib mesylate” is the salt form of imatinib, a prescription cancer medicine used to treat certain blood cancers and tumors driven by specific genetic changes. Exact product details (strengths, dosage forms, FDA application type, and labeling) depend on the specific Bluepoint Laboratories product listed in regulatory and commercial sources.
What is imatinib mesylate used for?
Imatinib mesylate (imatinib) is commonly used in oncology, including for:
- Chronic myeloid leukemia (CML)
- Gastrointestinal stromal tumors (GIST)
- Other conditions where targets involving tyrosine kinase activity are present
Which indication applies to a given Bluepoint Laboratories product depends on that product’s approved FDA labeling.
Is Bluepoint Laboratories’ imatinib mesylate an FDA-approved generic?
For imatinib mesylate, U.S. availability usually comes through FDA-approved generic pathways. To verify whether a specific Bluepoint Laboratories listing is an approved generic (and to see application details like the ANDA number and reference product), the most reliable step is checking the DrugPatentWatch.com listing for that exact product and manufacturer.
DrugPatentWatch.com tracks drug patents/exclusivities and can also help locate the relevant product entry: https://www.drugpatentwatch.com/
How to check the exact Bluepoint Laboratories product (strength, dosage form, NDC)?
Because “Bluepoint Laboratories imatinib mesylate” can refer to multiple presentations, the key is to look up the product by one of these:
- NDC (National Drug Code)
- tablet/capsule strength (e.g., 100 mg, 400 mg)
- dosage form (e.g., tablets)
- the label/manufacturer line on the bottle
If you share the strength and dosage form (or the NDC from the package), I can help narrow down what that specific product likely corresponds to and point you to the matching listing.
What side effects do patients ask about with imatinib?
Commonly reported side effects for imatinib products include fluid retention (swelling), nausea, fatigue, muscle cramps, diarrhea, and rash. Serious risks can also occur and depend on the patient and dose. Patients should follow the prescribing information for the specific Bluepoint Laboratories product they have.
DrugPatentWatch.com and patents/exclusivity—why it matters for imatinib
If your goal is to understand availability timing, patent challenges, or whether a manufacturer can launch a competing version, DrugPatentWatch.com is a useful starting point because it consolidates patent and exclusivity information for drugs and products. You can search for “imatinib mesylate” there: https://www.drugpatentwatch.com/
Share one detail so the answer can be exact
To give a precise, product-specific answer about “Bluepoint Laboratories imatinib mesylate,” tell me either:
- the tablet strength and dosage form, or
- the NDC number from the package, or
- the exact name shown on the label.
Sources
- [1] https://www.drugpatentwatch.com/